The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery
Open accessAbstract
Targeted drug delivery is a promising alternative to overcome the limitations of classical chemotherapy. In an ideal targeted drug delivery system carrier nanoparticles would be directed to the tumor tissue and selectively release therapeutic molecules. As a novel approach, chitosan coated magnetic nanoparticles (CS MNPs) maintain a pH dependent drug delivery which provides targeting of drugs to the tumor site under a magnetic field. Among various materials, chitosan has a great importance as a pH sensitive, natural, biodegradable, biocompatible and bioadhesive polymer. The aim of this study was to obtain an effective targeted delivery system for Doxorubicin, using chitosan coated MNPs. Different sized CS MNPs were produced by in situ synthesis method. The anti-cancer agent Doxorubicin was loaded onto CS MNPs which were characterized previously. Doxorubicin loading was confirmed by FTIR. Drug loading and release characteristics, and stability of the nanoparticles were investigated. Our results showed that the CS MNPs have pH responsive release characteristics. The cellular internalization of Doxorubicin loaded CS MNPs were visualized by fluorescent microscopy. Doxorubicin loaded CS MNPs are efficiently taken up by MCF-7 (MCF-7/S) and Doxorubicin resistant MCF-7 (MCF-7/1 μM) breast cancer cells, which increases the efficacy of drug and also maintains overcoming the resistance of Doxorubicin in MCF-7/Dox cells. Consequently, CS MNPs synthesized at various sizes can be effectively used for the pH dependent release of Doxorubicin in cancer cells. Results of this study can provide new insights in the development of pH responsive targeted drug delivery systems to overcome the side effects of conventional chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.02.001 · Cited by 2,903
Magnetic nanoparticles in MR imaging and drug delivery
Sun, C., Lee, J. S. H., & Zhang, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.018 · Cited by 2,594
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.010 · Cited by 2,586
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Berger, J., Reist, M., Mayer, J. M., Felt, O., Peppas, N. A., & Gurny, R. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00161-9 · Cited by 2,163
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,032
Polysaccharides-based nanoparticles as drug delivery systems
Liu, Z., Jiao, Y., Wang, Y., Zhou, C., & Zhang, Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.001 · Cited by 1,732
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., Bailey, K., Balagurunathan, Y., Rothberg, J. M., Sloane, B. F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2796 · Cited by 1,397
Gupta, A. K., Naregalkar, R. R., Vaidya, V. D., & Gupta, M. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.23 · Cited by 708
Pharmaceutical applications of chitosan
Dodane, V., & Vilivalam, V. D. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00059-5 · Cited by 663
pH-Responsive Copolymer Assemblies for Controlled Release of Doxorubicin
Gillies, E. R., & Fréchet, J. M. J. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049851c · Cited by 550
Extracellular pH distribution in human tumours
Engin, K., Leeper, D. B., Cater, J. R., Thistlethwaite, A. J., Tupchong, L., & McFarlane, J. D. (1995) · International Journal of Hyperthermia · doi:10.3109/02656739509022457 · Cited by 530
Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery
Kayal, S., & Ramanujan, R. V. (2010) · Materials Science and Engineering: C · doi:10.1016/j.msec.2010.01.006 · Cited by 495
Biocompatibility of Chitosan Carriers with Application in Drug Delivery
Rodrigues, S., Dionísio, M., López, C. R., & Grenha, A. (2012) · Journal of Functional Biomaterials · doi:10.3390/jfb3030615 · Cited by 389
Unsoy, G., Yalcin, S., Khodadust, R., Gunduz, G., & Gunduz, U. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0964-8 · Cited by 354
Self-citationTığlı Aydın, R. S., & Pulat, M. (2012) · Journal of Nanomaterials · doi:10.1155/2012/313961 · Cited by 324
In vivo imaging of extracellular pH using1H MRSI
van Sluis, R., Bhujwalla, Z. M., Raghunand, N., Ballesteros, P., Alvarez, J., Cerd�n, S., Galons, J.-P., & Gillies, R. J. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199904)41:4<743::aid-mrm13>3.0.co;2-z · Cited by 322
Controlled and extended drug release behavior of chitosan-based nanoparticle carrier
Yuan, Q., Shah, J., Hein, S., & Misra, R. D. K. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.08.027 · Cited by 308
Chitosan nanoparticles: a survey of preparation methods
Grenha, A. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.654121 · Cited by 305
Shu, X. Z., & Zhu, K. J. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00052-8 · Cited by 294
The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles
Decuzzi, P., & Ferrari, M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.013 · Cited by 261
Park, J. S., Han, T. H., Lee, K. Y., Han, S. S., Hwang, J. J., Moon, D. H., Kim, S. Y., & Cho, Y. W. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.011 · Cited by 250
Lim, E., Huh, Y., Yang, J., Lee, K., Suh, J., & Haam, S. (2011) · Advanced Materials · doi:10.1002/adma.201100351 · Cited by 220
Formulation and characterization of amphotericin B–chitosan–dextran sulfate nanoparticles
TIYABOONCHAI, W., & LIMPEANCHOB, N. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.013 · Cited by 173
Zeng, X., Morgenstern, R., & Nyström, A. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.042 · Cited by 136
Sahu, S. K., Mallick, S. K., Santra, S., Maiti, T. K., Ghosh, S. K., & Pramanik, P. (2010) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-010-3998-4 · Cited by 136
Review: doxorubicin delivery systems based on chitosan for cancer therapy
Tan, M. L., Choong, P., & Dass, C. R. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp/61.02.0001 · Cited by 134
Dextran–doxorubicin/chitosan nanoparticles for solid tumor therapy
Bisht, S., & Maitra, A. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.43 · Cited by 127
Kars, G., İşeri, Ö. D., Gündüz, U., Ural, A. U., Arpacı, F., & Molnár, J. (2006) · PubMed · Cited by 113
Longhi, A., Ferrari, S. M., Bacci, G., & Specchia, S. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32803d36fe · Cited by 97
Riganti, C., Voena, C., Kopecka, J., Corsetto, P. A., Montorfano, G., Enrico, E., Costamagna, C., Rizzo, A. M., Ghigo, D., & Bosia, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2001389 · Cited by 86
Ojugo (1999) · doi:10.1002/(sici)1099-1492(199912)12:8
Cited by
Kocak, G., Tuncer, C., & Bütün, V. (2017) · Polymer Chemistry · doi:10.1039/c6py01872f · Cited by 1,189
DNA Nanotechnology-Enabled Drug Delivery Systems
Hu, Q., Li, H., Wang, L., Gu, H., & Fan, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00663 · Cited by 1,118
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Vangijzegem, T., Stanicki, D., & Laurent, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 548
Magnetic nanoparticles in nanomedicine: a review of recent advances
Wu, K., Su, D., Liu, J., Saha, R., & Wang, J.-P. (2019) · Nanotechnology · doi:10.1088/1361-6528/ab4241 · Cited by 509
Liang, Y., Zhao, X., Ma, P. X., Guo, B., Du, Y., & Han, X. (2019) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.10.056 · Cited by 433
Metadata
- Authors
- Unsoy, G., Khodadust, R., Yalcin, S., Mutlu, P., & Gunduz, U.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 62
- Pages
- 243-250
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2063994057
- Cited by
- 333
- References
- 33
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.